Evidence map›Paper›PMID 21765345›Full record

ArticleCritical care medicine2011

Induction of cellular antioxidant defense by amifostine improves ventilator-induced lung injury.

Panfeng Fu, Jeffrey S Murley, David J Grdina, Anna A Birukova, Konstantin G Birukov

Abstract read
In one paragraph

Article in Critical care medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. IsLife (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. The Journal of biological chemistry · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cyclic stretch-induced oxidative stress increases pulmonary alveolar epithelial permeability.American journal of respiratory cell and molecular biology · 2013
    Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Panfeng FuSection of Pulmonary and Critical Care, Lung Injury Center, Department of Medicine, University of Chicago, IL, USA.
Jeffrey S Murley
David J Grdina
Anna A Birukova
Konstantin G Birukov
Apple (Israel) · IL

Funding

Tissue Culture Biomechanical CoreP01HL058064 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LAL, RATNESHWAR · 1998 to 2012
$27.8M
TRANSLATIONAL RESEARCH UNIVERSITY OF CHICAGO: CLINICAL TRIALSUL1RR024999 · NCRR · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2007 to 2011
$25.3M
Control of Lung Permeability by Oxidized PhospholipidsR01HL076259 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BIRUKOV, KONSTANTIN · 2004 to 2023
$6.8M
Molecular control of lung endothelial barrier function in ALIR01HL087823 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BIRUKOV, KONSTANTIN · 2008 to 2020
$4.6M
Protective role of ANP in the models of acute lung injuryR01HL089257 · NHLBI · UNIVERSITY OF CHICAGO · PI BIRUKOVA, ANNA · 2009 to 2013
$1.9M
Delayed Radioprotection by ThiolsR01CA099005 · NCI · UNIVERSITY OF CHICAGO · PI GRDINA, DAVID J. · 2003 to 2006
$1.2M
NCI NIH HHS R01 CA099005NCI NIH HHS R01 CA99005NCRR NIH HHS UL1 RR024999NCRR NIH HHS UL1RR024999NHLBI NIH HHS HL076259NHLBI NIH HHS HL087823NHLBI NIH HHS HL89257NHLBI NIH HHS P01 HL058064NHLBI NIH HHS R01 HL076259NHLBI NIH HHS R01 HL087823NHLBI NIH HHS R01 HL089257PHS HHS P01-058064
6 · The paper itself

Abstract

objectivesTo test the hypothesis that preconditioning animals with amifostine improves ventilator-induced lung injury via induction of antioxidant defense enzymes. Mechanical ventilation at high tidal volume induces reactive oxygen species production and oxidative stress in the lung, which plays a major role in the pathogenesis of ventilator-induced lung injury. Amifostine attenuates oxidative stress and improves lipopolysaccharide-induced lung injury by acting as a direct scavenger of reactive oxygen and nitrogen species. This study tested effects of chronic amifostine administration on parameters of oxidative stress, lung barrier function, and inflammation associated with ventilator-induced lung injury.

designRandomized and controlled laboratory investigation in mice and cell culture.

settingUniversity laboratory. SUBJECTS: C57BL/6J mice.

interventionsMice received once-daily dosing with amifostine (10-100 mg/kg, intraperitoneal injection) 3 days consecutively before high tidal volume ventilation (30 mL/kg, 4 hrs) at day 4. Pulmonary endothelial cell cultures were exposed to pathologic cyclic stretching (18% equibiaxial stretch) and thrombin in a previously verified two-hit model of in vitro ventilator-induced lung injury. MEASUREMENTS AND MAIN

resultsThree-day amifostine preconditioning before high tidal volume attenuated high tidal volume-induced protein and cell accumulation in the alveolar space judged by bronchoalveolar lavage fluid analysis, decreased Evans Blue dye extravasation into the lung parenchyma, decreased biochemical parameters of high tidal volume-induced tissue oxidative stress, and inhibited high tidal volume-induced activation of redox-sensitive stress kinases and nuclear factor-kappa B inflammatory cascade. These protective effects of amifostine were associated with increased superoxide dismutase 2 expression and increased superoxide dismutase and catalase enzymatic activities in the animal and endothelial cell culture models of ventilator-induced lung injury.

conclusionsAmifostine preconditioning activates lung tissue antioxidant cell defense mechanisms and may be a promising strategy for alleviation of ventilator-induced lung injury in critically ill patients subjected to extended mechanical ventilation.

Indexed as

AmifostineAnimalsAntioxidantsCells, CulturedEndotheliumFree Radical ScavengersInflammationLungMiceMice, Inbred C57BLOxidative StressReactive Oxygen SpeciesSignal TransductionVentilator-Induced Lung InjuryAmifostineAntioxidantsFree Radical ScavengersReactive Oxygen Species

Identifiers

PMID21765345
PMCPMC3657468
OpenAlexW2049897839

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.